Biotricity, Inc. (BTCY)

Market Cap	16.33M
Revenue (ttm)	12.06M
Net Income (ttm)	-14.93M
Shares Out	21.48M
EPS (ttm)	-1.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,670
Open	0.800
Previous Close	0.799
Day's Range	0.751 - 0.847
52-Week Range	0.701 - 3.750
Beta	1.41
Analysts	Hold
Price Target	n/a
Earnings Date	Jun 27, 2024

About BTCY

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City,...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Dr. Waqaas Al-Siddiq Ph.D.
• Employees: 55
• Stock Exchange: NASDAQ
• Ticker Symbol: BTCY

Financial Performance

In 2023, Biotricity's revenue was $12.06 million, an increase of 25.15% compared to the previous year's $9.64 million. Losses were -$14.93 million, -23.57% less than in 2022.